PROSPECTS FOR USING TOCILIZUMAB IN SYSTEMIC SCLEROSIS
Interleukin 6 (IL-6) is one of the key cytokines that are involved in inflammation and that has pleiotropic properties. Diverse effects of IL-6 result from the transmission of an intracellular signal in two ways: via direct binding to a membrane receptor having a molecular mass of 80 kDA (a classica...
| Published in: | Научно-практическая ревматология |
|---|---|
| Main Author: | |
| Format: | Article |
| Language: | Russian |
| Published: |
IMA PRESS LLC
2016-02-01
|
| Subjects: | |
| Online Access: | https://rsp.mediar-press.net/rsp/article/view/2155 |